Work

The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs

Year: 2003

Type: article

Source: Journal of Accounting Auditing & Finance

DOI: 10.1177/0148558x0301800109

Authors: Kirsten Ely, Paul J. Simko, L. G. Thomas

Institutions: Georgia Institute of Technology, University of Virginia, Emory University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

Open Access status: closed

OpenAlex ID: W345530192

FWCI: 8.373

Cites: 24

Cited by: 52

Related to: 10